ARTICLE | Company News
Nastech, Pohl-Boskamp morphine deal
September 26, 2001 7:00 AM UTC
NSTK granted G. Pohl-Boskamp (Hohenlockstedt, Germany) exclusive rights in Europe to develop and market NSTK's intranasal morphine to treat moderate-to-severe pain. NSTK will receive an upfront licens...